Economic Evaluations

Economic evaluations are fundamental in health to ensure limited resources are allocated in the most efficient way. They provide a structured, transparent approach to help decision-makers choose between alternative ways of using resources for health. The Swiss TPH offers a broad range of economic evaluation services including cost analyses, cost-effectiveness, cost-benefit and budget impact analyses.

Evaluating Effectiveness 

We work with partners in the public and private sector in Switzerland and with international agencies such as GAVI, GIZ, GFATM, and BMGF to support policy- and decision-makers in determining which options are efficient and affordable. Economic decision modelling on a global scale, such as the strategies to control and eliminate malaria , or at country level, such as the cost-effectiveness of introducing an innovative vaccine delivery system are examples of our profound experience in this area.

Health Financing

In addition, we provide advice to policy makers and donor agencies such as the Swiss Agency for Development and Cooperation about the routine inclusion of value-for-money analysis for their health sector programmes and projects.

The Swiss TPH offers a broad range of economic evaluation services including costing, cost-effectiveness, cost-benefit and budget impact analyses with the aim of ensuring limited resources are allocated in the most efficient way.


Cost-Benefit Model for Employee Health

Commissioned by the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), Swiss TPH developed a cost-benefit model for employers integrating epidemiological information for prioritizing employee health programs and analysing existing and potential interventions of employee health programs. The model has been implemented in Ghana, Tanzania, Kenya, Namibia and South Africa.

The model is accessible and usable in a wide range of organizational settings to help evidence-based prioritization of human resources health problems and enables cost-benefit analysis of interventions considered to alleviate these problems in a systematic way.

Link to Project

Impact Modeling of a Malaria Vaccine

With the support of the Malaria Vaccine Initiative (MVI) of PATH, Swiss TPH is carrying out simulations of the public health impact of the RTS,S malaria vaccine focusing on low income countries in sub-Saharan Africa and taking into account contextual factors such as the distributions of malaria transmission intensities. 

The work also involves cost-effectiveness analysis and budget impact analyses. Swiss TPH participates in model-validation exercises and comparisons of model results with those of other groups simulating RTS,S impact.

Link to Project